Literature DB >> 7878768

Apoptosis as a mechanism of cell death in liver allograft rejection.

S M Krams1, H Egawa, M B Quinn, J C Villanueva, R Garcia-Kennedy, O M Martinez.   

Abstract

It is generally recognized that there are two mechanisms of cell death, apoptosis and necrosis. Apoptosis--programmed cell death--is involved in numerous states of physiological cell deletion. Recent studies have demonstrated that hepatocytes, under certain conditions, undergo apoptosis. The purpose of this work was to determine if apoptotic cell death is involved in liver allograft rejection. Groups of Lewis (RT1l) rats underwent orthotopic liver transplantation (OLT) from disparate DA (RT1a) or syngeneic Lewis rats. Liver samples were harvested at 1, 2, 3, 4, and 7 days posttransplant and analyzed for apoptotic cell death. Since the characteristics of apoptosis are difficult to discern using routine hematoxylin and eosin staining, we utilized a novel method that detects the classic indicator of apoptosis, nonrandom DNA degradation. Paraffin-embedded tissue sections were end-labeled with nonradioactive dUTP and detection of apoptotic bodies accomplished by immunoassay. The incidence of apoptotic cells increased steadily over time in allografts, in contrast to syngeneic grafts. In this study apoptotic cell death paralleled standard indicators of liver allograft rejection including pathology, mononuclear cell infiltration, and increases in liver enzymes. Moreover, increased expression of TGF-beta 1 correlated with apoptosis in liver allografts, supporting the previously described role for this cytokine in hepatocyte apoptosis. Our results demonstrate, for the first time, that apoptosis may be a mechanism of cell death in liver allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7878768

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

Review 1.  Fas (CD95, Apo-1) ligand gene transfer.

Authors:  S E Lamhamedi-Cherradi; Y Chen
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

2.  Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene.

Authors:  G Bilbao; J L Contreras; D E Eckhoff; G Mikheeva; V Krasnykh; J T Douglas; F T Thomas; J M Thomas; D T Curiel
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

3.  Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver.

Authors:  Hannes A Rüdiger; Koo J Kang; David Sindram; Hans M Riehle; Pierre A Clavien
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720.

Authors:  X K Li; A Tamura; M Fujino; L Guo; T Kakefuda; N Funeshima; S Enosawa; M Amari; S Naoe; H Amemiya; S Suzuki
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

5.  Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Vladimir M Subbotin; Tadahiro Uemura; Michael Nalesnik; Anthony J Demetris; John J Fung; Thomas E Starzl
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

6.  Liver microRNA Profile of Induced Allograft Tolerance.

Authors:  Matthew James Vitalone; Liang Wei; Masato Fujiki; Audrey H Lau; Erik Littau; Carlos Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

7.  Activation of innate immunity (NK/IFN-gamma) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation.

Authors:  Kezhen Shen; Shu-Sen Zheng; Ogyi Park; Hua Wang; Zhaoli Sun; Bin Gao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-21       Impact factor: 4.052

8.  Functional analysis of grafts from living donors. Implications for the treatment of older recipients.

Authors:  J C Emond; J F Renz; L D Ferrell; P Rosenthal; R C Lim; J P Roberts; J R Lake; N L Ascher
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.

Authors:  R Josien; P Douillard; C Guillot; M Müschen; I Anegon; J Chetritt; S Menoret; C Vignes; J P Soulillou; M C Cuturi
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

10.  Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury.

Authors:  Erica Riddle-Taylor; Kazuhito Nagasaki; Joseph Lopez; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2007-09-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.